Article
Tumor macrophage functional heterogeneity can inform the development of novel cancer therapies.
Trends in immunology - 1 Dec 2023
Nasir Ibraheem, McGuinness Conor, Poh Ashleigh R, Ernst Matthias, Darcy Phillip K, Britt Kara L
Abstract excerpt
Macrophages represent a key component of the tumor microenvironment (TME) and are largely associated with poor prognosis. Therapeutic targeting of macrophages has historically focused on inhibiting their recruitment or reprogramming their phenotype from a protumor (M2-like) to an antitumor (M1-like) one. Unfortunately, this approach has not provided clinical breakthroughs that have changed practice. Emerging...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
